New Jersey cancer patients have the opportunity to take part in the largest study ever conducted by the American Cancer Society, according to an article posted on NJ.com.
The Cancer Prevention Study-3 will track 300,000 people across the nation for a minimum of 20 years to analyze how genetics, environment, and lifestyle contribute to the cause and/or prevention of cancer.
The American Cancer Society plans to launch a recruitment drive in October in Newark in cooperation with the University of Medicine and Dentistry of New Jersey and Newark Beth Israel Medical Center. National recruitment for the major study began in 2006, but the Society is making an extra effort to meet its goal of 300,000 subjects by December 2013. In order to participate in the study, a person must be between the ages of 30 and 65, and be willing to submit to a waist measurement, complete an extensive questionnaire, give a vial of blood, and grant the Society permission to contact them every year for between 20 and 30 years.
The findings of this study would be especially relevant in New Jersey, which claims higher than average cancer incidence and death rates than the rest of the U.S. More than 16,300 New Jersey residents died of cancer in 2011 and nearly 50,000 were diagnosed with the disease.
While prevention of cancer may somewhat rely on research and information, which this new study aims to collect, the actual survival of cancer patients depends on the actions of healthcare professionals.
If you have suffered or have lost a loved one as the result of a healthcare professional’s failure to diagnose your disease or provide appropriate treatment within the standards of medical care, there may be a basis for a medical negligence action.
The experienced NJ failure to diagnose cancer lawyers at Blume Forte can help you determine whether you may have a meritorious claim. Call us at (973) 635-5400 for a no-cost consultation regarding your legal rights and potential options.